|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.005 USD | -2.33% |
|
+17.74% | +13.71% |
| 07-08 | Outlook Therapeutics Receives UK Marketing Authorization for Eye Disease Drug | MT |
| 07-01 | Outlook Therapeutics, Inc.(NasdaqCM:OTLK) added to Russell Small Cap Comp Value Index | CI |
On January 6, 2023, Outlook Therapeutics, Inc. closed the transaction. The transaction included participation from one investor.
| 1st Jan change | Capi. | |
|---|---|---|
| +13.71% | 216M | |
| +24.97% | 47.96B | |
| +1.89% | 42.45B | |
| +44.47% | 41.47B | |
| +27.63% | 31.6B | |
| +21.43% | 28.63B | |
| -6.35% | 28.03B | |
| +52.27% | 14.56B | |
| +47.20% | 14.14B | |
| +4.12% | 12.58B |
OUTLOOK THERAPEUTICS, INC. 
